A study (29) demonstrated that high expression of IL-34 and M-CSF and their ligands was associated with lower survival in a cohort of lung cancer patients, because lung cancers with high IL-34 and M-CSF expression were more likely to progress to advanced stages. This evidence concerns the gene IL34 and lung carcinoma.